ARVINAS, INC. - 8-K Filing
Arvinas announced that Noah Berkowitz, M.D., Ph.D., its chief medical officer, will depart on July 3, 2026. Under the separation agreement, he is entitled to nine months of continued base salary and health coverage, as well as accelerated vesting for RSUs set to vest through May 9, 2027. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $ARVN